Comparison of basal bolus treatment with insulin aspart including insulin NPH [insulin suspension isophane] and biphasic insulin aspart [insulin aspart/insulin protamine aspart] in type 2 diabetes mellitus
Phase of Trial: Phase IV
Latest Information Update: 08 Jan 2017
At a glance
- Drugs Insulin aspart; Insulin aspart/insulin protamine aspart; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 10 Jun 2017 Biomarkers information updated
- 16 May 2009 Actual patient number (394) added as reported by ClinicalTrials.gov.
- 16 May 2009 Actual end date (Jul 2004) added as reported by ClinicalTrials.gov.